NEW YORK (GenomeWeb News) – Shimadzu USA Manufacturing said today it has obtained ISO 13485 certification for the manufacture of high performance liquid chromatographs and liquid chromatograph-mass spectrometry systems.

The certification allows Shimadzu USA Manufacturing to manufacture and supply analytical instruments for clinical testing in the US market, the company said, adding it will continue to register devices with the US Food and Drug Administration and support the growing demand for LC and LC-MS in the clinical testing space.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."